CLINICAL_TRIALS
trial_result
· 2016-02-02
Clinical Trial Update: A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C. [Phase 4]
Summary
Phase 4 trial update evaluating NeoRecormon (epoetin beta) for anemia in patients with hepatitis C; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: COMPLETED